| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |